sizofiran has been researched along with Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izumi, H; Sakurai, K; Sumiya, K | 1 |
| Aoshi, T; Ishii, KJ; Kobiyama, K; Mochizuki, S; Morishita, H; Sakurai, K | 1 |
| Aoshi, T; Coban, C; Hayashi, M; Ishii, KJ; Kanuma, T; Kitahata, Y; Kobayashi, N; Kobiyama, K; Kuroda, E; Kusakabe, T; Ozasa, K; Temizoz, B; Yamamoto, T; Yamaue, H | 1 |
| Rowan, NJ; Smith, JE; Sullivan, R | 1 |
| Borchers, AT; Gershwin, ME; Hackman, RM; Keen, CL; Stern, JS | 1 |
2 review(s) available for sizofiran and Neoplasms
| Article | Year |
|---|---|
Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine.
Topics: Agaricales; Antineoplastic Agents; Chemistry, Pharmaceutical; Humans; Lentinan; Medicine, East Asian Traditional; Neoplasms; Plants, Medicinal; Polysaccharides; Proteoglycans; Sizofiran | 2006 |
Mushrooms, tumors, and immunity.
Topics: Adjuvants, Immunologic; Agaricales; Animals; Antineoplastic Agents; beta-Glucans; Dextranase; Dietary Supplements; Glucans; Humans; Lentinan; Macrophages; Mice; Monocytes; Neoplasms; Sizofiran; T-Lymphocytes | 1999 |
3 other study(ies) available for sizofiran and Neoplasms
| Article | Year |
|---|---|
Enhanced Therapeutic Efficacy of Immunostimulatory CpG-ODN by Silencing SOCS-1 with Polysaccharide/miR-155 Complexes.
Topics: Adjuvants, Immunologic; Animals; Immunization; Mice; MicroRNAs; Neoplasms; Oligodeoxyribonucleotides; Sizofiran; Suppressor of Cytokine Signaling 1 Protein; Toll-Like Receptor 9 | 2023 |
Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
Topics: Adjuvants, Immunologic; Animals; Antigen-Presenting Cells; Cancer Vaccines; Cells, Cultured; Immunization; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Mice, Inbred C57BL; Neoplasms; Oligodeoxyribonucleotides; Ovalbumin; Peptide Fragments; Sizofiran; Spleen; T-Lymphocytes, Cytotoxic; Tissue Distribution; Tumor Burden | 2015 |
Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; CD8-Positive T-Lymphocytes; CpG Islands; Cytokines; Humans; Immunity, Innate; Interferon Type I; Interferon-gamma; Interleukin-12; Leukocyte Common Antigens; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nanoparticles; Neoplasms; Oligodeoxyribonucleotides; Phagocytosis; Sizofiran; Toll-Like Receptor 9; Tumor Microenvironment | 2016 |